Avanos Medical, Inc. trades on NYSE under the ticker AVNS.
Trailing-twelve-month figures tagged in Avanos Medical, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $715.90M |
|---|---|
| Net income (TTM) | -$74.40M |
| EPS (TTM) | -$1.60 |
| Gross margin | 50.05% |
| Operating margin | -8.80% |
| Return on equity | -9.51% |
| Cash | $65.60M |
Invest a chosen dollar amount in Avanos Medical, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AVNS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.